drugset / Trial / NCT00433615
Clinical Study of R744 to Predialysis Patients
Non-randomizedParallel-groupOpen-labelTreatment
Summary
This study will assess the efficacy and safety of subcutaneous or intravenous R744 in renal anemia patients on Predialysis.
Timeline
- Start
- 2007-02
- Primary completion
- 2008-11
- Completion
- 2008-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | methoxy polyethylene glycol-epoetin beta | Protein / enzyme biologic | 25 ug | Subcutaneous |
| Subject | methoxy polyethylene glycol-epoetin beta | Protein / enzyme biologic | 400 ug | Subcutaneous |